Douglas Elliman (DOUG) Reports Q2 Loss of $0.05

Douglas Elliman (NYSE: DOUG) reported Q2 EPS of ($0.05), versus $0.00 reported last year. Revenue for the quarter came in at $283.45 million.

For earnings history and earnings-related data on Douglas Elliman (DOUG) click here.

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
• Jefferies Upgrades Inovio Pharmaceuticals (INO) to Buy
• HSBC Upgrades Pegatron Corp. (4938:TT) to Hold